Study With [225Ac]Ac-FL-020 in mCRPC Participants
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Recruiting · NCT06492122 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study With [225Ac]Ac-FL-020 in mCRPC Participants | Metastatic Castration-resistant Prostate Cancer | Recruiting | Phase 1 | 2026-05-26 | NCT06492122 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Full-Life Technologies UK Limited | 1 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ankara Üniversitesi Tıp Fakültesi Cebeci Hastanesi Nükleer Tıp Anabilim Dalı | Ankara | Turkey (Türkiye) | 1 |
| Beijing Cancer hospital | Beijing | China | 84 |
| Chao Family Comprehensive Cancer Center | Irvine | United States | 1 |
| City of Hope Medical Center | Duarte | United States | 313 |
| Genesiscare Murdoch | Murdoch | Australia | 1 |
| MacQuarie University Clinical Trial Unit | Sydney | Australia | 1 |
| Princess Alexandra Hospital | Brisbane | Australia | 11 |
| Renji Shanghai Hospital | Shanghai | China | 1 |
| University Hospital of Cleveland | Cleveland | United States | 6 |
| University of Stanford | Stanford | United States | 1 |
| University of Virginia Cancer Center | Charlottesville | United States | 11 |